Elevated Circulating Interleukin-17 Levels in Patients with Systemic Lupus Erythematosus: A Meta-analysis

Previous studies concerning the circulating interleukin-17 (IL-17) in systemic lupus erythematosus (SLE) were contradictory. To further precisely investigate circulating IL-17 in SLE and evaluate its influential factors by meta-analysis. EMBASE, PubMed and Cochrane Library were comprehensively searc...

Full description

Saved in:
Bibliographic Details
Published in:Immunological investigations 2020-08, Vol.49 (6), p.662-675
Main Authors: Shen, Hui-Hui, Fan, Ye, Wang, Ya-Ni, Zhao, Chan-Na, Zhang, Zhi-Kang, Pan, Hai-Feng, Wu, Guo-Cui
Format: Article
Language:English
Subjects:
IL-17
Interleukin 17
meta-analysis
SLE
systemic lupus erythematosus
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Previous studies concerning the circulating interleukin-17 (IL-17) in systemic lupus erythematosus (SLE) were contradictory. To further precisely investigate circulating IL-17 in SLE and evaluate its influential factors by meta-analysis. EMBASE, PubMed and Cochrane Library were comprehensively searched to obtain studies on circulating IL-17 in SLE patients by November 22, 2018. The results were illustrated by pooled standard mean difference (SMD) with corresponding 95% confidence interval (CI) using random-effects model as there was significant heterogeneity, which was estimated using Cochran Q and I 2 statistics. Subgroup analyses and sensitivity analyses were also conducted. Overall, 1872 articles were reviewed and 20 studies involving 1067 subjects with SLE and 721 healthy controls (HCs) were enrolled in the final analysis according to inclusion criteria. Compared with HCs, circulating IL-17 levels in SLE patients were elevated (SMD: 1.183, 95% CI: 0.763-1.603; P < .001). Moreover, in comparison to HCs, European and Asian SLE patients, age
ISSN:0882-0139
1532-4311
DOI:10.1080/08820139.2019.1699107